ProRelix Research proudly participated in the 17th Annual Conference of the Indian Society for Clinical Research (ISCR), held on 1–2 February 2024 at Hotel Novotel HICC, Hyderabad. This premier event brought together clinical research professionals, industry leaders, and regulatory experts to share knowledge, explore emerging trends, and discuss strategies to enhance patient outcomes through ethical and innovative clinical research practices.
Representing ProRelix Research at the conference were Dr. Sornaraja Thasma, Director of Business and Quality Assurance, and Mrs. Priyanka Bidave, Business Development Executive. Their presence underscored our organization’s commitment to fostering industry collaboration, advancing research quality, and driving excellence in clinical trial management.
The ISCR Annual Conference serves as a vital platform for engaging with thought leaders, understanding evolving regulatory landscapes, and adopting cutting-edge methodologies that align with global standards. Our participation reflects ProRelix Research’s dedication to staying at the forefront of industry advancements, ensuring that our clients benefit from the latest innovations and best practices in clinical research.
At ProRelix Research, we remain focused on our mission to deliver prompt, reliable, and ethical clinical trials that positively impact healthcare outcomes worldwide. The insights gained from the ISCR Conference will further strengthen our capabilities to support sponsors, CRO partners, and healthcare organizations in achieving their research goals.
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.